HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Knockdown of the transcript of ERK in the brain modulates hypothalamic neuropeptide-mediated appetite control in amphetamine-treated rats.

AbstractBACKGROUND AND PURPOSE:
Amphetamine is a releaser of dopamine stored in synaptic terminals, which can suppress appetite by changing the expression levels of neuropeptide Y (NPY) and proopiomelanocortin (POMC) in the hypothalamus. This study explored whether ERKs are involved in appetite control mediated by cAMP response element binding protein (CREB), NPY and POMC in amphetamine-treated rats.
EXPERIMENTAL APPROACH:
Rats were given amphetamine for 4 days, and changes in feeding behaviour and expression levels of phosphorylated-ERK (pERK), pCREB, NPY and melanocortin MC3 receptors were examined and compared.
KEY RESULTS:
Following amphetamine treatment, food intake, body weight and NPY expression decreased, whereas the expression of pERK, pCREB, MC3 receptors and pCREB/DNA binding activity increased. In amphetamine-treated rats, both cerebral ERK knockdown and pretreatment with a peripheral dopamine receptor antagonist decreased NPY but increased pERK, pCREB and MC3 receptor expression. Moreover, the immunofluorescence of hypothalamic pERK increased following amphetamine treatment.
CONCLUSIONS AND IMPLICATIONS:
These results suggest that ERK/CREB signalling participates in the effects mediated by dopamine receptor/NPY/POMC on appetite control in rats treated with amphetamine. These findings advance the knowledge on the involvement of ERK/CREB signalling in the reciprocal regulation by NPY and POMC of appetite after amphetamine treatment.
AuthorsChing-Han Yu, Yih-Shou Hsieh, Pei-Ni Chen, Jeng-Rung Chen, Dong-Yih Kuo
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 175 Issue 4 Pg. 726-739 (02 2018) ISSN: 1476-5381 [Electronic] England
PMID29215157 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2017 The British Pharmacological Society.
Chemical References
  • Cyclic AMP Response Element-Binding Protein
  • Neuropeptide Y
  • Receptors, Neuropeptide Y
  • Pro-Opiomelanocortin
  • Amphetamine
Topics
  • Amphetamine (pharmacology)
  • Animals
  • Appetite Regulation (drug effects, physiology)
  • Cyclic AMP Response Element-Binding Protein (genetics, metabolism)
  • Eating (drug effects, physiology)
  • Feeding Behavior (drug effects, physiology)
  • Gene Knockdown Techniques (methods)
  • Hypothalamus (drug effects, metabolism)
  • MAP Kinase Signaling System (drug effects, physiology)
  • Male
  • Neuropeptide Y (antagonists & inhibitors, genetics, metabolism)
  • Pro-Opiomelanocortin (genetics, metabolism)
  • Rats
  • Rats, Wistar
  • Receptors, Neuropeptide Y (antagonists & inhibitors, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: